Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

Key facts

Sponsor

The George Washington University Biostatistics Center

Principal Investigator

Monica Longo, MD

NICHD Project Scientist

Intervention

Betamethasone(drug)

Enrollment

2831 enrolled

Eligibility

FEMALE

Timeline

2010 – 2022

Study locations (17)

• University of Alabama - Birmingham, Birmingham, Alabama, United States
• Stanford University, Stanford, California, United States
• University of Colorado, Denver, Colorado, United States
• Northwestern University, Chicago, Illinois, United States
• Wayne State University, Detroit, Michigan, United States
• Columbia University, New York, New York, United States
• University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
• Duke University, Durham, North Carolina, United States
• Case Western Reserve University, Cleveland, Ohio, United States
• Ohio State University, Columbus, Ohio, United States
• Oregon Health & Science University, Portland, Oregon, United States
• University of Pittsburgh Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
• Brown University, Providence, Rhode Island, United States
• University of Texas - Southwest, Dallas, Texas, United States
• University of Texas - Galveston, Galveston, Texas, United States
• +2 more locations on ClinicalTrials.gov

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autoimmune lymphoproliferative syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT03328650
  Clinical Outcomes of the ALPS Proximal Humerus Plating System
  Vanderbilt University Medical Center

See all trials for Autoimmune lymphoproliferative syndrome →